Table 1. Clinical characters.
Case | Age (years) | Sex | Tumor size (centimeters) | WHO classification | Involved organs | Postoperative complications |
---|---|---|---|---|---|---|
1 | 61 | M | 3.0×2.5×2.0 | B2 | P | N |
2* | 56 | M | 4.0×3.5×3.0 | B1 | P | N |
3 | 47 | M | 7.5×6.5×4.0 | B2 | P | N |
4 | 54 | M | 7.0×3.0×3.0 | B2–B3 | P | N |
5* | 44 | M | 6.0×4.0×3.0 | B2–B3 | RUL | MC |
6 | 45 | F | 7.0×6.5×4.0 | B1 | P | N |
7 | 45 | F | 6.0×5.5×3.0 | AB | P | N |
8 | 69 | M | 6.0×6.0×5.0 | B2–B3 | P | AF |
9* | 70 | M | 6.0×5.0×5.0 | B2–B3 | P | N |
10* | 53 | M | 3.0×2.0×2.0 | B1–B2 | RUL | N |
11 | 67 | M | 5.0×4.0×3.0 | B2–B3 | LIV | N |
12* | 52 | F | 4.0×4.0×4.0 | B2–B3 | P | N |
13 | 46 | M | 5.0×4.0×3.0 | B2–B3 | P, LIV | N |
*, Co-morbidity: ocular myasthenia gravis. F, female; M, male; WHO, World Health Organization; RUL, right upper lobe; LIV, left innominate vein; P, pericardium; N, none; MC, myasthenic crisis; AF, atrial fibrillation.